Streetbeat News

Price Targets

FBLG

Maxim Group has initiated coverage on FibroBiologics with a Buy rating and set a price target of $12.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 12:59 pm

AIR

RBC Capital analyst Ken Herbert has reiterated an Outperform rating for AAR Corp (NYSE:AIR) and maintained a price target of $85.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 12:58 pm

BRZE

Loop Capital has reiterated its Buy rating on Braze (NASDAQ:BRZE) and maintained a price target of $75.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 12:54 pm

PINS

Oppenheimer has initiated coverage on Pinterest with an Outperform rating and set a price target of $45.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 12:51 pm

LUMO

EF Hutton has initiated coverage on Lumos Pharma with a Buy rating and set a price target of $16, indicating a positive outlook for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 12:51 pm

ALTM

RBC Capital has reiterated its Outperform rating on Arcadium Lithium (NYSE:ALTM) and maintained a price target of $3.1.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 12:51 pm

BANC

BNTX

BRZE

CART

CELH

CMA

HUT

LNW

MCK

XOM

Top Wall Street analysts have updated their price targets and ratings for several companies, including Exxon Mobil, Hut 8, McKesson, BioNTech, Banc of California, Maplebear, Comerica, Celsius Holdings, Braze, and Light & Wonder. These changes reflect varying outlooks on the stocks, with some being upgraded and others downgraded.

Portfolio Pulse from Avi Kapoor

September 24, 2024 | 12:50 pm

ENGN

Oppenheimer analyst Leland Gershell has reiterated an Outperform rating on enGene Holdings (NASDAQ:ENGN) and maintained a $30 price target.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 12:50 pm

TLN

Oppenheimer analyst Ian Zaffino has maintained an 'Outperform' rating on Talen Energy and raised the price target from $165 to $210.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 12:48 pm

LOW

Oppenheimer has upgraded Lowe's Companies (NYSE:LOW) from Perform to Outperform, raising the price target from $230 to $305.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 12:46 pm